Design Pharmaceuticals Inc. Email Format
Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees
Design Pharmaceuticals Inc. is a Cambridge, Massachusetts-based pharmaceutical manufacturing company focused on accelerating GPCR drug discovery through ultra-high throughput bioscience technologies. Its platform aims to broaden functional screening across a wide range of GPCR targets, enabling the identification of hit candidates more efficiently and with reduced compound requirements, while also allowing analysis of potential off-target effects. The approach is modality agnostic, supporting small molecules, peptides, or antibody libraries, and can be adapted to include GPCR variants for drug function assays. Customers are researchers and teams seeking faster exploration of drug space within the GPCR field, addressing diseases that currently lack satisfactory therapies. The company positions itself within the biotechnology landscape as a specialized screening and discovery engine, leveraging a cell-based, multiplex GPCR screening capability to advance functional readouts in living cells, with ongoing development in droplet microfluidics to scale screening of large libraries.